Evidence map›Paper›PMID 33389485›Full record

ArticleMycopathologia2021

Geldanamycin-Induced Morphological Changes Require Candida albicans Hyphal Growth Regulatory Machinery.

Stephen P Saville, Ian A Cleary

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Stephen P SavilleDepartment of Biology, The South Texas Center for Emerging Infectious Diseases, The University of Texas At San Antonio, San Antonio, TX, USA.
Ian A ClearyDepartment of Biomedical Sciences, Grand Valley State University, One Campus Drive, Allendale, MI, 49401, USA. clearyia@gvsu.edu.ORCID https://orcid.org/0000-0002-3958-431X
Grand Valley State University · USTexas Center for Infectious Disease · US

Funding

NRG1 Regulated Genes in Candida albicans PathogenicityR01AI063256 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI SAVILLE, STEPHEN P · 2006 to 2009
$1.1M
National Institute of Allergy and Infectious Diseases AI063256-01
6 · The paper itself

Abstract

In Candida albicans, geldanamycin treatment inhibits the essential chaperone Hsp90 and induces a change from yeast to filamentous morphology, likely by impeding cell cycle progression and division. However, filaments formed by wild-type cells upon geldanamycin exposure are quite different in appearance from true hyphae. We have observed that effects on morphology caused by geldanamycin treatment appear to vary in strains with defects in different morphological regulators. These results indicate that the filamentous forms induced by inhibiting Hsp90p, while not true hyphae, nonetheless require some components of the hypha induction machinery for their formation. Furthermore, we have found that BRG1, a known regulator of hypha formation, is also required for pseudohypha induction in response to nitrogen starvation and for the formation of elongated filaments upon exposure to geldanamycin.

Indexed as

Candida albicansFungal ProteinsBenzoquinonesGene Expression Regulation, FungalHyphaeLactams, MacrocyclicBenzoquinonesFungal ProteinsgeldanamycinLactams, MacrocyclicBRG1Candida albicansHSP90HyphaeNRG1

Identifiers

PMID33389485
OpenAlexW3119376518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.